Research Site

Pontevedra 36312

1 studies enrolling now · 8 studies all time

What they study most

Breast Cancer, Carcinoma, Coronary Heart Disease (CHD), Crohn's Disease, Diabetes Mellitus, Type 2, ER-Positive HER2-Negative Breast Cancer, IBD, Metastatic Breast Cancer, Multiple Sclerosis, Non-Small-Cell Lung

Studies at this site

• A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer — Recruiting now
• Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment — Running, not enrolling
• An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease — Stopped early
• Efficacy and Safety of MEDI6570 in Patients With a History of Myocardial Infarction — Completed
• Dimethyl Fumarate (DMF) Observational Study — Completed
• A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus — Completed
• A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer — Completed
• Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer — Completed